Monteresearch, an EMS Group Company, Secures Exclusive Global License for Repurposed Niclosamide in Helicobacter pylori Infection
Bollate (MI), Italy – March 25, 2026 – Monteresearch s.r.l., an Italian drug-delivery company and part of EMS Group, today announced that it has secured an exclusive worldwide license from a leading U.S. academic research institution for intellectual property covering the repurposing of niclosamide for the treatment of Helicobacter pylori infection. H. pylori infections affect […]